E. Bayram, "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy," BMC CANCER , vol.23, pp.136-146, 2023
Bayram, E. 2023. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC CANCER , vol.23 , 136-146.
Bayram, E., (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC CANCER , vol.23, 136-146.
Bayram, ERTUĞRUL. "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy," BMC CANCER , vol.23, 136-146, 2023
Bayram, ERTUĞRUL. "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy." BMC CANCER , vol.23, pp.136-146, 2023
Bayram, E. (2023) . "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy." BMC CANCER , vol.23, pp.136-146.
@article{article, author={ERTUĞRUL BAYRAM}, title={Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy}, journal={BMC CANCER}, year=2023, pages={136-146} }